经导管心臟瓣膜置换术 (THVR) 的全球市场（2023-2030）：按产品和手术方法分類的规模、份额、成长分析和预测

Global Transcatheter Heart Valve Replacement Market Size, Share, Growth Analysis, By Product, By Surgical Approach - Industry Forecast 2023-2030

出版日期: 2023年09月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球经导管心臟瓣膜置换术（THVR）市场规模预计将从2021年的53.3亿美元增长到2022年的57.1亿美元，预测期内年复合成长率为7.2%，到2030年预计将增长到美国106.8亿美元。

由于技术进步、人口高龄化和心血管疾病的增加，THVR 市场正在经历显着成长。与传统的心臟直视手术相比，经导管技术降低了手术风险并缩短了恢復时间。市场领先的公司不断创新，使其设备更加耐用，并将其适用性扩展到更广泛的患者群体。市场扩张也得益于意识的提高、有利的报销政策以及医疗保健专业人员和製造商之间的合作配合措施。

市场趋势

技术进步和创新正在再形成THVR 市场形势。这些进步使得先进的、侵入性较小的手术成为可能。显着的增强包括复杂的阀门结构、升级的影像模式和新颖的输送机制。这一演变最大限度地减少了併发症，扩大了可治疗的患者范围，并支持了将 THVR 作为解决主动脉瓣疾病最佳方法的趋势。

本报告调查了全球经导管心臟瓣膜置换术（THVR）市场，提供了市场概况，分析了市场上的各种影响因素、技术和创新趋势、法律制度、市场规模趋势和预测，并提供了各种资讯。总结了按类别和地区分類的细分、竞争形势以及主要企业的概况。

市场概况
市场规模
市场动态
- 促进因素
- 机会
- 抑制因素
- 任务
关键市场洞察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- 启动分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 重点投资分析
- 关键成功要素
- 竞争程度
市场动态及前景
- 市场动态
  - 促进因素
  - 机会
  - 抑制因素
  - 任务
- 法规状况
- 波特的分析
- Skyquest 对未来颠覆的独家见解
全球经导管心臟瓣膜置换术 (THVR) 市场：按产品
- 市场概况
- 经导管主动脉瓣置换术
- 经导管二尖瓣修復/替换
- 经导管肺动脉瓣置换术
全球经导管心臟瓣膜置换术 (THVR) 市场：依手术方法分类
- 市场概况
- 经股动脉路径
- 经心尖入路
- 经主动脉入路
全球经导管心臟瓣膜置换术（THVR）市场（按地区）
- 市场概况
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东/非洲
竞争形势
- 前5名企业对比
- 主要企业市场地位
- 主要企业的招募策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率
- 主要企业简介
- 4C Medical Technologies
- Abbott
- Boston Scientific
- Edwards Lifesciences
- HighLife Medical
- JC Medical
- LivaNova
- Medtronic plc
- Neovasc - Canada

简介目录

Product Code: SQMIG35D2143

Market Insights

Global Transcatheter Heart Valve Replacement Market size was valued at USD 5.33 billion in 2021 and is poised to grow from USD 5.71 billion in 2022 to USD 10.68 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The Global Transcatheter Heart Valve Replacement Market encompasses the medical sector focused on minimally invasive heart valve procedures. This market has witnessed significant growth due to advancements in technology, an aging population, and rising cardiovascular diseases. Transcatheter techniques offer reduced surgical risks and quicker recovery times compared to traditional open-heart surgeries. Leading market players are continually innovating to enhance device durability and expand application to a broader patient base. This market's expansion is driven by increased awareness, favorable reimbursement policies, and collaborative efforts between medical professionals and manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of transcatheter heart valve replacement and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segmental Analysis

The global transcatheter heart valve replacement market is segmented on the basis of product, surgical approach, application, end user, and region. By Product, the market is segmented into Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement, and Transcatheter Pulmonary Valve Replacement. By Surgical approach, the market is segmented into Transfemoral Approach, Transapical Approach, and Transaortic Approach. By Application, the market is segmented into Aortic Valve Stenosis, Aortic Valve Regurgitation, Aortic Valvular Heart Disease, Mitral Valvular Heart Disease, Mitral Valve Regurgitation, Mitral Valve Stenosis, and Pulmonary Valvular Heart Disease. By End user, the market is segmented into Hospitals, and Cath labs. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers

Factors such as the aging global populace and the growing prevalence of heart valve conditions like aortic stenosis are fueling the need for transcatheter heart valve replacement (THVR). With extended lifespans, the chances of encountering valve-related ailments are higher, thus enlarging the pool of patients seeking THVR interventions.

Restraints

Substantial Initial Expenses and Reimbursement Constraints:

Commencing THVR procedures involves significant financial outlays, encompassing device acquisition and specialized apparatus. Furthermore, obstacles in reimbursement coupled with divergent healthcare regulations across geographical areas might impede patient admission and moderate market proliferation.

Market Trends

Technological progress and innovations are reshaping the landscape of the Transcatheter Heart Valve Replacement (THVR) market. These advancements are yielding sophisticated and less invasive procedures. Notable enhancements include refined valve configurations, upgraded imaging methods, and novel delivery mechanisms, collectively ensuring safer and more efficient interventions. This evolution minimizes complications, broadens the spectrum of suitable patients, and propels the preference for THVR as the optimal approach to address aortic valve conditions.